SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

Considerations for Bifurcation Stenting

Bifurcation lesions need optimal vessel healing to reduce risk of Stent Thrombosis (ST)
The SYNERGY stent shows evidence of early healing and excellent strut coverage in multiple OCT Analyses ranging from 30 days to 6 months1
comparison graphic

Bifurcation lesions are often tapered
The SYNERGY Stent has a labeled overexpansion limit2 of up to 5.75mm, allowing the physician to customize the stent to the appropriate vessel size and ensure great apposition.
synergy overexpansion indication graphic


Bifurcation PCI benefits from an appropriate Cell Diameter & Expansion
The SYNERGY Stent has large cell diameters in the body of the stent to accommodate side branch access3

 

Model Diameter Size(s) # of Connectors Proximal End MECD (mm) Rest of Stent body MECD (mm)
Small Vessel 2.25mm, 2.50mm & 2.75mm

4 on proximal end;

2 throughout stent body

2.3mm 4.5mm
Workhorse 3.00 & 3.50mm

4 on proximal end;

2 throughout stent body

2.7mm 5.5mm
Large Vessel 4.00mm

5 on proximal end;

2 throughout stent body

2.9mm* 7.1mm

With bifurcation stenting, it is important to maintain the natural vessel shape
The SYNERGY Stent’s customized architecture offers exceptional strength and conformability4
 

Radial Strength*

Conformability

 

SYNERGY Conformability Chart
* Radial Strength: Amount of radial force required to reduce the diameter of a deployed stent by 15%.
† Conformability: The amount of torque required to bend the stent to a specific curvature.

Boston Scientific is committed to supporting studies evaluating the SYNERGY Stent in patient populations that interventional Cardiologists see in their everyday practice, including bifurcation stenting.
synergy stent evaluating studies graphic
More information on the SYNERGY Investigator Sponsored Research
Top